OneMedNet (ONMD) Ratios
OneMedNet Ratios
ONMD's free cash flow for Q2 2026 was $-1.88M. For the 2026 fiscal year, ONMD's free cash flow was decreased by $-9.00K and operating cash flow was $-1.88M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.43 | 0.19 | 0.03 | 0.01 | 0.18 |
| Quick Ratio | 0.43 | 0.19 | 0.03 | 0.01 | 0.18 |
| Cash Ratio | 0.12 | 0.01 | 0.00 | 0.01 | 0.15 |
| Solvency Ratio | -0.53 | -0.51 | -2.53 | -1.10 | -0.44 |
| Operating Cash Flow Ratio | -1.56 | -0.36 | -0.37 | -0.18 | -0.39 |
| Short-Term Operating Cash Flow Coverage | -21.44 | -0.80 | -1.03 | -0.19 | -0.55 |
| Net Current Asset Value | $ -3.02M | $ -16.06M | $ -12.96M | $ -27.26M | $ -5.75M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.26 | 2.35 | 11.02 | 20.36 | 5.55 |
| Debt-to-Equity Ratio | -0.19 | -0.55 | -0.40 | -1.00 | -0.86 |
| Debt-to-Capital Ratio | -0.24 | -1.22 | -0.66 | -226.23 | -6.08 |
| Long-Term Debt-to-Capital Ratio | -0.08 | 0.00 | -0.04 | -0.06 | -0.37 |
| Financial Leverage Ratio | -0.73 | -0.23 | -0.04 | -0.05 | -0.15 |
| Debt Service Coverage Ratio | -6.40 | -1.11 | -7.26 | -1.21 | -0.77 |
| Interest Coverage Ratio | -144.28 | -65.34 | -623.00 | -19.13 | -13.87 |
| Debt to Market Cap | 0.01 | 0.23 | 0.89 | 0.21 | 0.03 |
| Interest Debt Per Share | 0.14 | 0.32 | 0.72 | 2.20 | 0.34 |
| Net Debt to EBITDA | 0.01 | -0.87 | -0.15 | -0.85 | -1.54 |
| Profitability Margins | |||||
| Gross Profit Margin | -37.01% | -43.70% | -12.63% | -31.22% | -10.39% |
| EBIT Margin | -201.10% | -1552.10% | -3305.68% | -2639.55% | -251.47% |
| EBITDA Margin | -196.32% | -1543.23% | -3302.94% | -2637.38% | -250.14% |
| Operating Profit Margin | -711.33% | -1493.78% | -671.20% | -669.12% | -248.27% |
| Pretax Profit Margin | -206.03% | -1574.96% | -3306.76% | -2639.55% | -269.37% |
| Net Profit Margin | -206.11% | -1575.27% | -3308.52% | -2641.02% | -269.37% |
| Continuous Operations Profit Margin | -206.11% | -1575.27% | -3308.52% | -2641.02% | -269.37% |
| Net Income Per EBT | 100.04% | 100.02% | 100.05% | 100.06% | 100.00% |
| EBT Per EBIT | 28.96% | 105.43% | 492.66% | 394.48% | 108.50% |
| Return on Assets (ROA) | -130.22% | -271.77% | -7295.00% | -2362.37% | -333.03% |
| Return on Equity (ROE) | 94.47% | 63.50% | 262.68% | 115.52% | 51.57% |
| Return on Capital Employed (ROCE) | 361.52% | 61.96% | 55.40% | 31.09% | 70.08% |
| Return on Invested Capital (ROIC) | 415.96% | 142.55% | 88.61% | 10715.28% | 523.17% |
| Return on Tangible Assets | -130.22% | -271.77% | -7295.00% | -2362.37% | -333.03% |
| Earnings Yield | -5.72% | -26.53% | -588.70% | -24.04% | -1.95% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.75 | 3.02 | 6.73 | 60.68 | 11.90 |
| Payables Turnover | 0.00 | 0.15 | 0.27 | 1.29 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 24.27 | 5.95 | 10.33 | 13.89 | 21.94 |
| Asset Turnover | 0.63 | 0.17 | 2.20 | 0.89 | 1.24 |
| Working Capital Turnover Ratio | -0.15 | -0.05 | -0.05 | -0.08 | -0.42 |
| Cash Conversion Cycle | 132.95 | -2395.77 | -1273.88 | -277.93 | 30.67 |
| Days of Sales Outstanding | 132.95 | 120.91 | 54.21 | 6.01 | 30.67 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 2516.68 | 1328.09 | 283.94 | 0.00 |
| Operating Cycle | 132.95 | 120.91 | 54.21 | 6.01 | 30.67 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.68 | -0.25 | -0.68 | -0.39 | -0.12 |
| Free Cash Flow Per Share | -1.69 | -0.25 | -0.68 | -0.39 | -0.13 |
| Dividend Paid and CapEx Coverage Ratio | -577.15 | -136.92 | -108.89 | -81.09 | -61.61 |
| Capital Expenditure Coverage Ratio | -577.15 | -136.92 | -108.89 | -81.09 | -61.61 |
| Operating Cash Flow Coverage Ratio | -13.16 | -0.80 | -0.94 | -0.18 | -0.38 |
| Operating Cash Flow to Sales Ratio | -5.52 | -10.86 | -4.69 | -4.08 | -1.69 |
| Free Cash Flow Yield | -15.34% | -18.42% | -84.26% | -3.76% | -1.24% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -18.33 | -3.78 | -0.17 | -4.16 | -51.38 |
| Price-to-Sales (P/S) Ratio | 36.06 | 59.38 | 5.62 | 109.85 | 138.40 |
| Price-to-Book (P/B) Ratio | -16.53 | -2.39 | -0.45 | -4.81 | -26.50 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -6.52 | -5.43 | -1.19 | -26.60 | -80.61 |
| Price-to-Operating Cash Flow Ratio | -6.53 | -5.47 | -1.20 | -26.93 | -81.92 |
| Price-to-Earnings Growth (PEG) Ratio | 0.22 | 0.04 | -0.00 | -0.00 | -9.76 |
| Enterprise Value Multiple | -18.36 | -4.71 | -0.32 | -5.02 | -56.86 |
| Enterprise Value | 48.99M | 46.78M | 10.79M | 152.63M | 155.30M |
| EV to EBITDA | -18.36 | -4.71 | -0.32 | -5.02 | -56.86 |
| EV to Sales | 36.05 | 72.75 | 10.57 | 132.38 | 142.24 |
| EV to Free Cash Flow | -6.52 | -6.65 | -2.23 | -32.06 | -82.85 |
| EV to Operating Cash Flow | -6.53 | -6.70 | -2.25 | -32.45 | -84.20 |
| Tangible Book Value Per Share | -0.67 | -0.57 | -1.82 | -2.17 | -0.38 |
| Shareholders’ Equity Per Share | -0.67 | -0.57 | -1.82 | -2.17 | -0.38 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
| Revenue Per Share | 0.31 | 0.02 | 0.14 | 0.10 | 0.07 |
| Net Income Per Share | -0.63 | -0.36 | -4.77 | -2.51 | -0.20 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.02 | 1.01 | 1.00 | 1.00 | 1.07 |
| Research & Development to Revenue | 1.11 | 2.28 | 2.02 | 1.38 | 0.59 |
| SG&A to Revenue | 5.63 | 12.22 | 3.47 | 11.17 | 1.10 |
| Stock-Based Compensation to Revenue | 1.50 | 0.98 | 1.44 | 1.62 | 0.09 |
| Income Quality | 2.68 | 0.69 | 0.14 | 0.15 | 0.63 |
Currency in USD
